| 摘要 |
<p>The present invention relates to compounds of the formula (I) and the pharmaceutically acceptable forms thereof; wherein X, Y, a, b, c, d, R<1>, R<2>, R<3>, R<4> and R<5> are as defined herein. Moreover, the present invention is also directed at pharmaceutical compositions comprising a compound of the formula (I) and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed at methods of using the herein described compounds and compositions for treating or preventing a disorder or condition that can be treated or prevented by antagonizing the CCR1 receptor in a mammal.</p> |
| 申请人 |
PFIZER PRODUCTS INC.;BLUMBERG, LAURA, COOK;BROWN, MATTHEW, FRANK;GAWECO, ANDERSON, SEE;GLADUE, RONALD, PAUL;HAYWARD, MATTHEW, MERRILL;LUNDQUIST, GREGORY, DEAN;POSS, CHRISTOPHER, STANLEY;SHAVNYA, ANDRE |
发明人 |
BLUMBERG, LAURA, COOK;BROWN, MATTHEW, FRANK;GAWECO, ANDERSON, SEE;GLADUE, RONALD, PAUL;HAYWARD, MATTHEW, MERRILL;LUNDQUIST, GREGORY, DEAN;POSS, CHRISTOPHER, STANLEY;SHAVNYA, ANDRE |
